Recombinant Escherichia coli patZ Protein ，His & Myc

The patZ gene, derived from the plasmid pAD1 of Enterococcus faecalis, encodes a peptide with antimicrobial activity against several Gram-positive bacteria. Research on patZ recombinant protein has gained momentum due to its potential applications in combating antibiotic resistance, a major global health concern. The increasing prevalence of multidrug-resistant bacterial strains necessitates the discovery of novel antimicrobial agents, and patZ presents an exciting candidate due to its unique mechanism of action, which targets bacterial cell walls. Initial studies indicate that patZ exhibits a strong inhibitory effect on the growth of pathogens like Staphylococcus aureus and Listeria monocytogenes. By cloning and expressing patZ in suitable host systems such as Escherichia coli, researchers aim to produce the recombinant protein in larger quantities for further investigation. Detailed characterization of the recombinant patZ, including its stability, activity, and interaction with bacterial targets, is crucial for understanding its therapeutic potential. Furthermore, examining the structure-activity relationship of patZ could lead to the development of enhanced derivatives with improved efficacy. Given the urgent need for new antimicrobial strategies, the ongoing research into patZ and its recombinant protein form represents a promising avenue for the development of novel antibacterial therapies.